Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lipocine Inc (NASDAQ:LPCN)

3.71
Delayed Data
As of Oct 17
 -0.07 / -1.85%
Today’s Change
3.03
Today|||52-Week Range
5.33
+0.82%
Year-to-Date
No recent news for Lipocine Inc.

Today’s Trading

Previous close3.78
Today’s open3.79
Day’s range3.69 - 3.93
Volume214,794
Average volume (3 months)369,847
Market cap$76.7M
Dividend yield--
Data as of 10/17/2017

Growth & Valuation

Earnings growth (last year)+6.31%
Earnings growth (this year)+11.22%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.63

Competitors

 Today’s
change
Today’s
% change
ARQLArQule Inc+0.01+0.93%
EIGREiger BioPharmaceuti...-0.35-2.95%
MRNSMarinus Pharmaceutic...+0.06+1.14%
NOVNNovan Inc+0.02+0.40%
Data as of 10/17/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$19.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Mahesh V. Patel
CFO, Secretary, Principal Accounting Officer &
EVP
Morgan R. Brown
Corporate headquarters
Salt Lake City, Utah

Forecasts